Lima, M.R. et al. 2019. Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis. European Journal of Case Reports in Internal Medicine. 6, 2 (Feb. 2019). DOI:https://doi.org/10.12890/2019_001046.